Latest Boston Scientific Corporation Stories
PARIS, May 15, 2014 /PRNewswire/ -- Boston Scientific Reinforces Its Commitment to Global Education and Innovation
PREDICt-RM Collaborative Study between Boston Scientific, American College of Cardiology and Yale University Highlights Improved Outcomes in ICD and CRT-D Patients followed with the LATITUDE(TM) System
Boston Scientific Shockless Implant Evaluation (SIMPLE) Study Results Presented at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions NATICK, Mass., May
Advanced Illumina(TM) 3D Programming Software Provides Highly Significant Pain Relief in Study Patients NATICK, Mass., May 8, 2014 /PRNewswire/ -- New retrospective data highlighting the Boston
Innovative Technology Designed to Treat Intrauterine Fibroids and Polyps NATICK, Mass.
Global medical solutions innovator seeks to pioneer new research into effective treatments for heart failure and related cardiac conditions NATICK, Mass., May 6,
Promising Clinical Data to be Presented at Annual Conference NATICK, Mass., May 1, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will present select abstracts and
NATICK, Mass., May 1, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2014 Healthcare Conference on May 13 in
NATICK, Mass., May 1, 2014 /PRNewswire/ -- Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has launched the Promus PREMIER(TM) Everolimus-Eluting
Company Exceeds Earnings Per Share Guidance on the Strength of Continued Revenue Growth NATICK, Mass., April 29, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated
- a slit in a tire to drain away surface water and improve traction.